Steven Cohen Caribou Biosciences, Inc. Transaction History
Point72 Asset Management, L.P.
- $36 Billion
- Q2 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 2,343,540 shares of CRBU stock, worth $6.44 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,343,540
Previous 2,343,540
-0.0%
Holding current value
$6.44 Million
Previous $3.84 Million
-0.0%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding CRBU
# of Institutions
140Shares Held
53.1MCall Options Held
32.5KPut Options Held
89.8K-
Black Rock Inc. New York, NY6.95MShares$19.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.54MShares$12.5 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC4.16MShares$11.4 Million0.0% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA4.08MShares$11.2 Million0.34% of portfolio
-
Elmwood Wealth Management, Inc.2.18MShares$5.98 Million1.91% of portfolio
About Caribou Biosciences, Inc.
- Ticker CRBU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,840,800
- Market Cap $167M
- Description
- Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...